Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

September 21, 2016

"Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the United Nations’s (UN) Political Declaration Antimicrobial Resistance, which recognizes the need to address – at the highest political levels – the complex issue of drug-resistant infections, which affect people in every part of the world. Now, governments have the responsibility to turn these words into action and fully implement nationally-tailored plans and global commitments to combat antimicrobial resistance (AMR).

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

August 25, 2016

Dr. Erlend Grønningen from Trondheim, Norway is a Doctors Without Borders/Médecins Sans Frontières (MSF) supervising medical doctor at Boost Hospital in Lashkar Gah, capital of Afghanistan’s Helmand province. Dr Gronningen arrived in Afghanistan in April, 2016, and primarily focuses on internal medicine, as well as the diagnosis and treatment of tuberculosis (TB). This is his second assignment with MSF, having worked in South Sudan in 2014.

August 03, 2016

Doctors Without Borders/Médecins Sans Frontières (MSF) has recently begun a vaccination campaign to protect people who have a higher risk of contracting Cholera in Juba, South Sudan. The first phase of the campaign will cover 4,000 people living at the Protection of Civilians (PoC) site in Tomping. The vaccinations will take place on Wednesday (27 July) and Thursday (28 July).

July 29, 2016

JUBA, SOUTH SUDAN/NEW YORK, JULY 29, 2016 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is responding to a cholera outbreak in Juba by vaccinating people at high risk, providing clean drinking water and supporting medical treatment, as more than 300 cases have been recorded in the city, including five deaths.

May 27, 2016

Mandera County, in northeastern Kenya, is the latest to be affected by an ongoing cholera outbreak that has been spreading throughout the country for the past 17 months. Since April 2016, almost 800 cases have been reported in Mandera, including 11 deaths. The outbreak is concentrated in Mandera Township, home to around 90,000 people.

May 19, 2016

The O’Neill Report is the British Government’s response to tackling the emerging antibiotic resistance crisis. In order to overcome this global threat, all countries must play their part and take action to address the crisis, including funding research and development for new tools—new classes of antibiotics, but also diagnostics and vaccines—while ensuring sustainable and affordable access for those new tools. At the same time, steps need to be taken to conserve existing antibiotics for as long as possible.

May 17, 2016

There is a book kept under lock and key at all times in the tented HIV and tuberculosis (TB) ward of the Doctors Without Borders/Médecins Sans Frontières (MSF) hospital in Bentiu, South Sudan. It doesn’t look like much—its blue ink has started to fade and its pages emit a strong smell of must, mold, and swamp water.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

Pages